Cantor Fitzgerald’s Alethia Young on FDA approval for Biogen drug

Subscribe to The Global Herald in Google News

CNBC Television published this video item, entitled “Cantor Fitzgerald’s Alethia Young on FDA approval for Biogen drug” – below is their description.

Cantor Fitzgerald senior biotech analyst Alethia Young joins ‘Closing Bell’ to discuss the FDA approval for Biogen’s Alzheimer’s drug, calling this “one of the biggest approvals in biotech’s history.”

CNBC Television YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

Subscribe to The Global Herald in Google News

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • I do worry that inflation pressures are far from transitory, says former Dallas Fed president
  • Josh Brown: There are so many opportunities out there
  • Altimeter’s Brad Gerstner: Need to make sure your exposures allow you to play through corrections
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.